Moody’s assigns ‘Baa1’ rating to Summa Health’s bonds

Moody’s Investors Service assigned a “Baa1” rating to Akron, Ohio-based Summa Health’s proposed $344 million of series 2016 bonds.

Advertisement

The rating assignment is based on a number of factors, including Summa’s leading market position in its service area and strong unrestricted investments.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Summa’s operating cash flow and liquidity will remain relatively stable.

More articles on healthcare finance:
Envision Healthcare joins S&P 500 post merger
Ohio county outlines new ambulance billing rates: 4 things to know
NY physicians group picks Dimensional Insight’s analytics platform

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.